Index of artpub/2023/289919/

Munir, Talha
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes after Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study
2023
https://ddd.uab.cat/record/289919